SOUTH SAN FRANCISCO, Calif., Sept. 23, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company will present at the BioCentury NewsMakers in the Biotech Industry Conference on September 27 at the Millennium Broadway Hotel & Conference Center in New York City. KaloBios President and Chief Executive Officer, David W. Pritchard, will provide an overview of KaloBios and the company's three current clinical programs for its proprietary, patient-targeted monoclonal antibody therapeutics.
Company Presentation: When: Friday, September 27, 2013, 11:00 AM EDT Where: Millennium Broadway Hotel & Conference Center, New York City, NY
Webcast: To access the live and archived audio webcast of the NewsMakers presentation, please log on through a link located in the Investors section of the KaloBios Pharmaceuticals website under the Events & Presentations tab: http://www.visualwebcaster.com/event.asp?id=95820.
A replay of the webcast will be available one hour after the conclusion of the live event.
About KaloBios KaloBios Pharmaceuticals, Inc. is developing a portfolio of patient-targeted, first-in-class monoclonal antibodies to treat severe medical conditions with a primary clinical focus on respiratory diseases and cancer. For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.
Jeffrey H. Cooper Chief Financial Officer KaloBios Pharmaceuticals, Inc. (650) 243-3146 firstname.lastname@example.org
Joan E. Kureczka Kureczka/Martin Associates Tel: (415) 821-2413 Mobile: (415) 690-0210 Joan@Kureczka-Martin.com
SOURCE KaloBios Pharmaceuticals, Inc.